top of page

Student Grant Awarded to Rodrigo Santiago Lima

Updated: Apr 18, 2022

Neurodegenerative Disease Research is happy to announce the first recipient of the Funding Innovations in Neurodegenerative Diseases (FIND) program.

The $10,000 Student Grant for one year was awarded to Rodrigo Santiago Lima. Rodrigo is a masters student at the University of San Paulo, Brazil. He studies dysregulated lipid metabolism in ALS rodent models.

The dynamics and pathways of oxidized lipid species formation in ALS disease development and progression is lacking.

Rodrigo will investigate oxidized lipid species in ALS with a focus on reactive species that have been identified in the Miyamoto Laboratory. Additionally, he will quantitatively map lipids from the blood and spinal cord of ALS SOD1G93A rodent models at pre-symptomatic and symptomatic stages.

Rodrigo will present or publish his findings at the end of 2022.

Welcome to ALS research, Rodrigo!

41 views0 comments

Recent Posts

See All

TVALA Drug Trial

We are happy to announce the first patients are being screened for entry into the clinical trial for our drug TVALA! This Phase 1 study will wrap up in a few months and the Phase 2 will start, it will

Thymosin in the treatment of lung cancer

A new paper authored by Liu and Lu in the Frontiers in Immunology reports the Mechanism and clinical application of thymosin in the treatment of lung cancer. Thymosin is a mixture of peptides obtained


We are hopeful that TVALA will reduce p53 expression in people with ALS. There are two recent publications that give us hope. The first paper is by Maor-Nof et. al. (2022), found in Cell. The found


Commenting has been turned off.
bottom of page